These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2111678)

  • 1. [Cellular mechanisms of pulmonary vasoconstriction in an experimental model of protamine reversal of heparin].
    Montalescot G
    Arch Mal Coeur Vaiss; 1990 Apr; 83(4):555-60. PubMed ID: 2111678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging the ovine heparin-protamine interaction with 111In-protamine.
    Montalescot G; Fischman AJ; Strauss HW; Wilkinson RA; Ahmad M; Fitzgibbon C; Robinson DW; Zapol WM
    J Appl Physiol (1985); 1993 Aug; 75(2):963-71. PubMed ID: 8226502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb.
    Kurrek MM; Winkler M; Robinson DR; Zapol WM
    Anesthesiology; 1995 Jan; 82(1):183-7; discussion 31A. PubMed ID: 7832299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary reaction after protamine reversal of heparin in goats and rabbits].
    Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
    Masui; 1992 Aug; 41(8):1260-6. PubMed ID: 1433847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep.
    Montalescot G; Zapol WM; Carvalho A; Robinson DR; Torres A; Lowenstein E
    Circulation; 1990 Nov; 82(5):1754-64. PubMed ID: 2171807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of platelet depletion on lung vasoconstriction in heparin-protamine reactions.
    Montalescot G; Kreil E; Lynch K; Greene EM; Torres A; Carvalho A; Fitzgibbon C; Robinson DR; Lowenstein E; Zapol WM
    J Appl Physiol (1985); 1989 May; 66(5):2344-50. PubMed ID: 2745299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-protamine complexes cause pulmonary hypertension in goats.
    Horiguchi T; Enzan K; Mitsuhata H; Murata M; Suzuki M
    Anesthesiology; 1995 Oct; 83(4):786-91. PubMed ID: 7574058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
    Morel DR; Costabella PM; Pittet JF
    Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA; Heran CL; Ogletree ML
    Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
    Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
    Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protamine and pulmonary hypertension].
    Horiguchi T; Enzan K; Suzuki M
    Kokyu To Junkan; 1992 Jan; 40(1):43-8. PubMed ID: 1557557
    [No Abstract]   [Full Text] [Related]  

  • 12. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep.
    Montalescot G; Lowenstein E; Ogletree ML; Greene EM; Robinson DR; Hartl K; Zapol WM
    Circulation; 1990 Nov; 82(5):1765-77. PubMed ID: 2146041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation.
    Morel DR; Lowenstein E; Nguyenduy T; Robinson DR; Repine JE; Chenoweth DE; Zapol WM
    Circ Res; 1988 May; 62(5):905-15. PubMed ID: 3129208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of fibrinogen in protamine-induced pulmonary hypertension.
    Sogawa M; Mohammad SF
    J Surg Res; 1997 Nov; 73(1):80-4. PubMed ID: 9441797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a thromboxane receptor antagonist (NT-126) and a thromboxane synthase inhibitor (OKY-O46) on protamine-induced circulatory changes in dogs.
    Mizutani T; Takahashi S; Kihara S; Toyooka H
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):687-92. PubMed ID: 11139110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
    Nuttall GA; Murray MJ; Bowie EJ
    Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-protamine reactions in pigs: role of oxygen-derived free radicals.
    Vollmar B; Conzen PF; Habazettl H; Yekebas E; Peter K
    J Appl Physiol (1985); 1993 May; 74(5):2412-20. PubMed ID: 8335575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine model.
    Wakefield TW; Lindblad B; Whitehouse WM; Hantler CB; Stanley JC
    Surgery; 1986 Jul; 100(1):45-51. PubMed ID: 3726760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine-induced pulmonary venoconstriction in heparinized pigs.
    Hakim TS; Picone A; Oleary CE; Camporesi EM
    Anesth Analg; 1995 Jul; 81(1):38-43. PubMed ID: 7598279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet-activating factor in the ovine heparin-protamine reaction.
    Montalescot G; Huerta JM; Braquet P; Zapol WM
    J Appl Physiol (1985); 1992 Dec; 73(6):2604-7. PubMed ID: 1490976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.